I. Flisiak: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

51

411 HEPATITIS C VIRUS REAPPEARANCE IN HIV-INFECTED PATIENTS WITH SPONTANEOUS HCV-RNA CLEARANCE

L. Peters, A. Mocroft, V. Soriano, J. Rockstroh, N. Kirkby, P. Reiss, C. Katlama, N. Zakharova, R. Flisiak, J. Lundgren

Journal:

Journal of Hepatology

Year:

2009

Language:

english

File:

PDF, 106 KB

english, 2009

52

618 SUCCESSFUL ANTIVIRAL THERAPY IS ASSOCIATED WITH THE DECREASE OF SERUM PROHEPCIDICIN IN CHRONIC HEPATITIS C

J. Jaroszewicz, M. Rogalska, R. Flisiak

Journal:

Journal of Hepatology

Year:

2009

Language:

english

File:

PDF, 111 KB

english, 2009

53

946 PK-PD MODELING OF VIRAL KINETICS DURING TREATMENT WITH DEBIO-025 PLUS PEGYLATED INTERFERON ALPHA-2A IN TREATMENT-NAIVE HCV PATIENTS

E. Herrmann, A. Käfer, R. Flisiak, V. Nicolas-Métral, S. Zeuzem, R. Crabbe

Journal:

Journal of Hepatology

Year:

2009

Language:

english

File:

PDF, 114 KB

english, 2009

54

8 EARLY PREDICTION OF SUSTAINED RESPONSE TO PEGINTERFERON ALFA-2A IN HBEAG-NEGATIVE PATIENTS: THE ROLE OF ON-TREATMENT HBSAG AND HBV DNA LEVELS

V. Rijckborst, B.E. Hansen, Y. Cakaloglu, P. Ferenci, F. Tabak, M. Akdogan, K. Simon, U.S. Akarca, R. Flisiak, E. Verhey, A.J. van Vuuren, C.A.B. Boucher, M.J. ter Borg, H.L.A. Janssen

Journal:

Journal of Hepatology

Year:

2010

Language:

english

File:

PDF, 106 KB

english, 2010

55

306 RELATION OF INSULIN RESISTANCE AND HEPATIC STEATOSIS WITH ADVANCED HEPATIC FIBROSIS IN PATIENTS WITH GENOTYPE 1 OR 2/3 CHRONIC HEPATITIS C

A. Thompson, M. Grigorescu, R. Flisiak, A. Horban, M. Buti, V. Rehak, K. Han, R. Safadi, M. Cho, M. Torbenson, G. Subramanian, J. McHutchison

Journal:

Journal of Hepatology

Year:

2010

Language:

english

File:

PDF, 71 KB

english, 2010

56

267 CYSTATIN C MEASUREMENT MAY IDENTIFY ASYMPTOMATIC RENAL DYSFUNCTION IN CHRONIC HEPATITIS C PATIENTS

J. Jaroszewicz, M. Rogalska, T. Szulzyk, R. Flisiak

Journal:

Journal of Hepatology

Year:

2010

Language:

english

File:

PDF, 50 KB

english, 2010

57

755 SUSTAINED VIROLOGICAL RESPONSE AFTER 4-WEEK TREATMENT WITH DEBIO 025 MONOTHERAPY OR COADMINISTERED WITH PEG-IFNα2A IN HCV GENOTYPE 1 AND 3 PATIENTS

A. Horban, H. Berak, A. Kolakowska-Rzadzka, H. Patel, R. Flisiak, R. Crabbé, J.S. Liz, J.E. Heathcote

Journal:

Journal of Hepatology

Year:

2010

Language:

english

File:

PDF, 50 KB

english, 2010

58

748 EFFICACY OF STANDARD OF CARE THERAPY FOLLOWING EXPERIMENTAL DEBIO 025 TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS C

R. Flisiak, M. Woynarowski, M. Jablkowski, W. Halota, W. Kryczka, A. Horban, A. Czauz-Andrzejuk, J. Bialkowska, M. Pawlowska, D. Zarebska-Michaluk, J. Kierkus, R. Crabbé, J. Liz

Journal:

Journal of Hepatology

Year:

2010

Language:

english

File:

PDF, 52 KB

english, 2010

59

972 SERUM CONCENTRATION OF FAS, FASL, CYTOCHROME C AND M30-NEOEPITOPE OF CYTOKERATIN-18 IN CHRONIC HEPATITIS C

A. Parfieniuk-Kowerda, T.W. Lapinski, M. Rogalska-Plonska, M. Rogalska, J. Pogorzelska, R. Flisiak

Journal:

Journal of Hepatology

Year:

2010

Language:

english

File:

PDF, 48 KB

english, 2010

60

4 ONCE DAILY ALISPORIVIR (DEB025) PLUS PEGIFNALFA2A/RIBAVIRIN RESULTS IN SUPERIOR SUSTAINED VIROLOGIC RESPONSE (SVR24) IN CHRONIC HEPATITIS C GENOTYPE 1 TREATMENT NAIVE PATIENTS

R. Flisiak, J.-M. Pawlotsky, R. Crabbé, P.I. Calistru, W. Kryczka, D. Haüssinger, G. Mazzella, M. Romero-Gomez, D. Purcea, G. Vuagniaux, W. Bao, C. Avila, S. Zeuzem

Journal:

Journal of Hepatology

Year:

2011

Language:

english

File:

PDF, 42 KB

english, 2011

61

126 A PHASE-2B TRIAL TO EVALUATE THE SAFETY, TOLERABILITY AND EFFICACY OF A CASPASE INHIBITOR GS-9450, IN ADULTS FAILING PEG/RBV THERAPY FOR CHRONIC HCV INFECTION

M. Manns, M. Palmer, R. Flisiak, E. DeJesus, L. Hazan, W. Liang, D. Oldach, J. McHutchison, K. Hirsch

Journal:

Journal of Hepatology

Year:

2011

Language:

english

File:

PDF, 59 KB

english, 2011

62

445 A PHASE 2B TRIAL COMPARING 24 TO 48 WEEKS TREATMENT WITH TEGOBUVIR (GS-9190)/PEG/RBV TO 48 WEEKS TREATMENT WITH PEG/RBV FOR CHRONIC GENOTYPE 1 HCV INFECTION

E. Lawitz, I. Jacobson, E. Godofsky, G.R. Foster, R. Flisiak, M. Bennett, M. Ryan, J. Hinkle, J. Simpson, J. McHutchison, D. Oldach

Journal:

Journal of Hepatology

Year:

2011

Language:

english

File:

PDF, 100 KB

english, 2011

63

424 RESPIRATORY ALTERATIONS IN GENOTYPE 2/3 CHRONIC HEPATITIS C PATIENTS TREATED WITH PEGYLATED INTERFERON OR ALBINTERFERON-ALFA-2B PLUS RIBAVIRIN IN A RANDOMIZED STUDY

G. Foster, R. Flisiak, W.-L. Chuang, J. George, J. Rasenack, A. Sood, P. Komolmit, S. Thongsawat, T. Tanwandee, R. Sola, W. Sukeepaisarnjaroen, M. Weltman, Y. Yin, G. Feutren, K. Brown

Journal:

Journal of Hepatology

Year:

2011

Language:

english

File:

PDF, 120 KB

english, 2011

64

10 PEGINTERFERON LAMBDA-1A (LAMBDA) COMPARED TO PEGINTERFERON ALFA-2A (ALFA) IN TREATMENT-NAIVE PATIENTS WITH HCV GENOTYPES (G) 2 OR 3: FIRST SVR24 RESULTS FROM EMERGE PHASE IIB

S. Zeuzem, S. Arora, B. Bacon, T. Box, M. Charlton, M. Diago, D. Dieterich, R.E. Mur, G. Everson, M. Fallon, P. Ferenci, R. Flisiak, J. George, R. Ghalib, N. Gitlin, A. Gladysz, S. Gordon, S. Greenblo

Journal:

Journal of Hepatology

Year:

2012

Language:

english

File:

PDF, 82 KB

english, 2012

65

466 SERUM IP-10 IN THE NATURAL COURSE OF HBEAG(-) PERSISTENT HBV-INFECTION

J. Jaroszewicz, M. Luto, A. Parfieniuk-Kowerda, M. Plonska-Rogalska, T.W. Lapinski, R. Flisiak

Journal:

Journal of Hepatology

Year:

2012

Language:

english

File:

PDF, 57 KB

english, 2012

66

O.101 A novel primboost therapeutic vaccine induces sustained seroconversion at 52 weeks in patients with HBeAg+ chronic hepatitis B: A phase IIa clinical trial

J. Schneider, W. Halota, D. Delic, Z. Nesic, D. Prokopowicz, R. Flisiak, J. Kuydowicz, M. Jablkowski, J. Cianciara, T. Mach, R. Modrzewska, M. Fabri, D. Tomic, A. Horban, W. Krycka, M. Cripps

Journal:

Journal of Clinical Virology

Year:

2006

Language:

english

File:

PDF, 146 KB

english, 2006

67

O.127 Phase 2b interim (week 12) results of albumin interferon alpha-2b combined with ribavirin in IFN-naïve, genotype 1 chronic hepatitis C infection

Y. Benhamou, S. Zeuzem, D. Shouval, V. Bain, S. Pianko, R. Flisiak, M. Grigorescu, V. Rehak, E. Yoshida, K. Kaita, C. Hezode, A.U. Neumann, M. Subramanian, J. McHutchison

Journal:

Journal of Clinical Virology

Year:

2006

Language:

english

File:

PDF, 276 KB

english, 2006

68

Randomized trial of albinterferon alfa-2b every 4 weeks for chronic hepatitis C virus genotype 2/3

S. Pianko, S. Zeuzem, W.-L. Chuang, G. R. Foster, S. K. Sarin, R. Flisiak, C.-M. Lee, P. Andreone, T. Piratvisuth, S. Shah, A. Sood, J. George, M. Gould, P. Komolmit, S. Thongsawat, T. Tanwandee, J. R

Journal:

Journal of Viral Hepatitis

Year:

2012

Language:

english

File:

PDF, 309 KB

english, 2012

69

Effect of ulcerative colitis treatment on transforming growth factor β1 in plasma and rectal mucosa

Alicja Wiercińska-Drapało, Robert Flisiak, Danuta Prokopowicz

Journal:

Regulatory Peptides

Year:

2003

Language:

english

File:

PDF, 132 KB

english, 2003

70

Effect of lamivudine treatment on plasma levels of transforming growth factor beta 1, tissue inhibitor of metalloproteinases-1 and metalloproteinase-1 in patients with chronic hepatitis B

R. Flisiak, D. Prokopowicz, T. Lapinski

Journal:

Journal of Hepatology

Year:

2003

Language:

english

File:

PDF, 161 KB

english, 2003

71

Serological response against Borrelia afzelii antigens in acrodermatitis chronica atrophicans

I. Flisiak, B. Chodynicka, C. Łukaszuk

Journal:

Journal of the European Academy of Dermatology and Venereology

Year:

1998

Language:

english

File:

PDF, 119 KB

english, 1998

72

The concentrations of IL-22, sFas and sFasL in HCV, HIV and HCV/HIV infections

Tadeusz Wojciech Łapiński, Robert Flisiak, Alicja Wiercińska-Drapało Joanna Pogorzelska, Magda Rogalska

Journal:

HIV & AIDS Review

Year:

2007

Language:

english

File:

PDF, 144 KB

english, 2007

73

Cystatin C as a new biomarker of renal dysfunction in HIV-1 infected patients – preliminary report

Robert Kranc, Magdalena Monika Dąbrowska, Alicja Wiercinska-Drapało, Robert Flisiak

Journal:

HIV & AIDS Review

Year:

2008

Language:

english

File:

PDF, 100 KB

english, 2008

74

Cyclophilin Inhibitors

Robert Flisiak, Anna Parfieniuk-Kowerda

Journal:

Current Hepatitis Reports

Year:

2012

Language:

english

File:

PDF, 159 KB

english, 2012

75

Tenofovir DF (TDF) showed superior antiviral efficacy to adefovir dipivoxil in a randomized, double-blind, study for the treatment of HBeAg-positive chronic hepatitis B (CHB)

P. Andreone, J. Heathcote, M. Rizzetto, E. Gane, R. DeMan, S. Lee, R. Flisiak, J. Sorbel, J. Anderson, E. Mondou, F. Rousseau

Journal:

Digestive and Liver Disease

Year:

2008

Language:

english

File:

PDF, 61 KB

english, 2008

76

Cost-Effectiveness of Truncated Therapy for Hepatitis C Based on Rapid Virologic Response

Ziad F. Gellad, Andrew J. Muir, John G. McHutchison, William Sievert, Ala I. Sharara, Kimberly A. Brown, Robert Flisiak, Ira M. Jacobson, David Kershenobich, Michael P. Manns, Kevin A. Schulman, Shelb

Journal:

Value in Health

Year:

2012

Language:

english

File:

PDF, 2.02 MB

english, 2012

77

Effect of chronic B hepatitis activity on plasma transforming growth factor-beta 1 concentration

Robert Flisiak, Danuta Prokopowicz, Jerzy Jaroszewicz, Anatol Panasiuk

Journal:

Journal of Hepatology

Year:

2001

Language:

english

File:

PDF, 147 KB

english, 2001

78

Albinterferon Alfa-2b Was Not Inferior to Pegylated Interferon-α in a Randomized Trial of Patients With Chronic Hepatitis C Virus Genotype 2 or 3

David R. Nelson, Yves Benhamou, Wan–Long Chuang, Eric J. Lawitz, Maribel Rodriguez–Torres, Robert Flisiak, Jens W.F. Rasenack, Wiesław Kryczka, Chuan–Mo Lee, Vincent G. Bain, Stephen Pianko, Keyur Pat

Journal:

Gastroenterology

Year:

2010

Language:

english

File:

PDF, 981 KB

english, 2010

79

Three-Year Efficacy and Safety of Tenofovir Disoproxil Fumarate Treatment for Chronic Hepatitis B

E. Jenny Heathcote, Patrick Marcellin, Maria Buti, Edward Gane, Robert A. De Man, Zahary Krastev, George Germanidis, Samuel S. Lee, Robert Flisiak, Kelly Kaita, Michael Manns, Iskren Kotzev, Konstanti

Journal:

Gastroenterology

Year:

2011

Language:

english

File:

PDF, 1.67 MB

english, 2011

80

Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B

Marcellin, Patrick, Heathcote, E. Jenny, Buti, Maria, Gane, Ed, de Man, Robert A., Krastev, Zahary, Germanidis, George, Lee, Sam S., Flisiak, Robert, Kaita, Kelly, Manns, Michael, Kotzev, Iskren, Tche

Journal:

Boston Medical and Surgical Journal

Year:

2008

Language:

english

File:

PDF, 775 KB

english, 2008

81

Plasma transforming growth factor β 1 as a biomarker of psoriasis activity and treatment efficacy

Flisiak, Iwona, Porębski, Piotr, Flisiak, Robert, Chodynicka, Bożena

Journal:

Year:

2003

Language:

english

File:

PDF, 154 KB

english, 2003

82

Effect of psoriasis activity on VEGF and its soluble receptors concentrations in serum and plaque scales

Flisiak, Iwona, Zaniewski, Przemysław, Rogalska, Magdalena, Myśliwiec, Hanna, Jaroszewicz, Jerzy, Chodynicka, Bożena

Journal:

Year:

2013

Language:

english

File:

PDF, 131 KB

english, 2013

83

Metabolic syndrome and hepatitis C infection - brothers in arms

Jaroszewicz, Jerzy, Flisiak, Robert

Journal:

Liver International

Year:

2013

Language:

english

File:

PDF, 98 KB

english, 2013

84

Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection

Jacobson, Ira M., McHutchison, John G., Dusheiko, Geoffrey, Di Bisceglie, Adrian M., Reddy, K. Rajender, Bzowej, Natalie H., Marcellin, Patrick, Muir, Andrew J., Ferenci, Peter, Flisiak, Robert, Georg

Journal:

Boston Medical and Surgical Journal

Year:

2011

Language:

english

File:

PDF, 643 KB

english, 2011

85

The effect of the severity of liver cirrhosis on the level of lipids and lipoproteins

Chrostek, Lech, Supronowicz, Lukasz, Panasiuk, Anatol, Cylwik, Bogdan, Gruszewska, Ewa, Flisiak, Robert

Journal:

Clinical and Experimental Medicine

Year:

2014

Language:

english

File:

PDF, 227 KB

english, 2014

86

Emerging treatments for hepatitis C

Flisiak, Robert, Jaroszewicz, Jerzy, Parfieniuk-Kowerda, Anna

Journal:

Expert Opinion on Emerging Drugs

Year:

2013

Language:

english

File:

PDF, 360 KB

english, 2013

87

1360 PEGYLATED INTERFERON-LAMBDA (PEGIFN-λ) SHOWS SUPERIOR VIRAL RESPONSE WITH IMPROVED SAFETY AND TOLERABILITY VERSUS PEGIFNα-2A IN HCV PATIENTS (Gl/2/3/4): EMERGE PHASE IIB THROUGH WEEK 12

Zeuzem, S., Arora, S., Bacon, B., Box, T., Charlton, M., Diago, M., Dieterich, D., Mur, R. Esteban, Everson, G., Fallón, M., Ferenci, P., Flisiak, R., George, J., Ghalib, R., Gitlin, N., Gladysz, A.,

Journal:

Journal of Hepatology

Year:

2011

Language:

english

File:

PDF, 67 KB

english, 2011

88

HBV mutations and their clinical significance

Łapiński, TW, Pogorzelska, J, Flisiak, R

Journal:

Advances in Medical Sciences

Year:

2012

Language:

english

File:

PDF, 526 KB

english, 2012

89

1925 – The frequency of different types of seizures in children suffered from autism and epilepsy

Jedrzejczyk-Goral, B., Flisiak-Antonijczuk, H., Kalinowski, R.

Journal:

European Psychiatry

Year:

2013

Language:

english

File:

PDF, 30 KB

english, 2013

90

737 POLYMORPHISMS NEAR THE IL28B GENE ARE NOT ASSOCIATED WITH RESPONSE TO PEGINTERFERON IN HBeAg-NEGATIVE CHRONIC HEPATITIS B PATIENTS

Brouwer, W.P., Arends, P., Rijckborst, V., ter Borg, M.J., Cakaloglu, Y., Ferenci, P., Tabak, F., Akdogan, M., Simon, K., Raptopoulou-Gigi, M., Örmeci, N., Akarca, U.S., Flisiak, R., Hansen, B., Boons

Journal:

Journal of Hepatology

Year:

2013

Language:

english

File:

PDF, 69 KB

english, 2013

91

816 RIBAVIRIN DOSE REDUCTION DURING TELAPREVIR CONTAINING TRIPLE THERAPY DOES NOT AFFECT EARLY VIROLOGIC RESPONSE IN NON-RESPONDERS AND RELAPSERS WITH ADVANCED LIVER FIBROSIS

Janczewska, E., Flisiak, R., Berak, H., Zarebska-Michaluk, D., Dobracka, B., Pisula, A., Horban, A., Kryczka, W., Dobracki, W., Librant-Suska, M., Kozielewicz, D., Lojewski, W., Jurczyk, K., Lapinski,

Journal:

Journal of Hepatology

Year:

2013

Language:

english

File:

PDF, 76 KB

english, 2013

92

1862 – The effects of eeg-neurofeedback on adhd symptoms and eeg parameters

Flisiak-Antonijczuk, H., Kalinowski, R., Adamowska, S., Nowak, M., Piątak, P.

Journal:

European Psychiatry

Year:

2013

Language:

english

File:

PDF, 41 KB

english, 2013

93

1405 ALISPORIVIR PLUS RIBAVIRIN IS HIGHLY EFFECTIVE AS INTERFERON-FREE OR INTERFERON-ADD-ON REGIMEN IN PREVIOUSLY UNTREATED HCV-GT2 OR GT3 PATIENTS: SVR12 RESULTS FROM VITAL-1 PHASE 2B STUDY

Pawlotsky, J.-M., Sarin, S.K., Foster, G., Peng, C.-Y., Rasenack, J., Flisiak, R., Piratvisuth, T., Wedemeyer, H., Chuang, W.-L., Zhang, W.M., Naoumov, N.V.

Journal:

Journal of Hepatology

Year:

2012

Language:

english

File:

PDF, 59 KB

english, 2012

94

543 INTERLEUKIN 17F CONCENTRATION IS ASSOCIATED WITH DEGREE OF LIVER DAMAGE IN ALCOHOLIC LIVER DISEASE

Parfieniuk-Kowerda, A., Szulzyk, T., Swiderska, M., Lapinski, T.W., Jaroszewicz, J., Flisiak, R.

Journal:

Journal of Hepatology

Year:

2013

Language:

english

File:

PDF, 60 KB

english, 2013

95

BCAA in treatment of experimental hepatic encephalopathy /HE/

Boroń, P., Flisiak, R., Kwiatkowska, B., Pytel, B., Zdrodowska, J.

Journal:

Journal of Hepatology

Year:

1990

Language:

english

File:

PDF, 118 KB

english, 1990

96

P1126 IMPACT OF SAFETY-RELATED DOSE REDUCTIONS AND DISCONTINUATIONS (SR-RD) ON SUSTAINED VIROLOGICAL RESPONSE (SVR) IN TREATMENT-NAIVE CHRONIC HEPATITIS C PATIENTS RECEIVING PEGINTERFERON ALFA-2a/RIBAVIRIN: RESULTS FROM GUARD-C

Foster, G.R., Coppola, C., Curescu, M., Derbala, M., Esmat, G., Ferenci, P., Flisiak, R., Lengyel, G., Mangia, A., Orlandini, A., Reddy, K.R., Rodriguez-Torres, M., Shiffman, M.L., Sporea, I., Tallari

Journal:

Journal of Hepatology

Year:

2014

Language:

english

File:

PDF, 56 KB

english, 2014

97

Treatment of chronic hepatitis C in a patient with Fanconi anaemia

Rogalska-Płońska, M, Parfieniuk-Kowerda, A, Łapiński, TW, Flisiak, R

Journal:

Advances in Medical Sciences

Year:

2011

Language:

english

File:

PDF, 450 KB

english, 2011

98

P677 HEPATIC STEATOSIS DOES NOT PREDICT REGRESSION OF LIVER CIRRHOSIS IN CHRONIC HEPATITIS B (CHB) PATIENTS TREATED WITH TENOFOVIR DISOPROXIL FUMARATE (TDF)

Buti, M., Washington, M.K., Gane, E., Aguilar Schall, R., Bornstein, J.D., Subramanian, M., McHutchison, J.G., Flisiak, R., Janssen, H.L.A., Marcellin, P.

Journal:

Journal of Hepatology

Year:

2014

Language:

english

File:

PDF, 73 KB

english, 2014

99

P1169 EFFECT OF PEGYLATED INTERFERON OR RIBAVIRIN DOSE REDUCTION DURING TELAPREVIR BASED THERAPY ON SVR12 IN NULL-RESPONDERS AND RELAPSERS WITH ADVANCED LIVER FIBROSIS (ADVEX STUDY)

Zarebska-Michaluk, D., Flisiak, R., Janczewska, E., Berak, H., Dobracka, B., Librant-Suska, M., Kozielewicz, D., Lojewski, W., Jurczyk, K., Lapinski, T., Musialik, J., Postawa-Klosinska, B., Wroblewsk

Journal:

Journal of Hepatology

Year:

2014

Language:

english

File:

PDF, 61 KB

english, 2014

100

P1119 EARLY VIRAL KINETICS DO NOT PREDICT TREATMENT OUTCOME WITH SOFOSBUVIR + RIBAVIRIN FOR 12 OR 24 WEEKS IN HCV GENOTYPE 2/3 PATIENTS IN THE VALENCE TRIAL

Zeuzem, S., Dusheiko, G.M., Colombo, M., Flisiak, R., Hyland, R.H., Illeperuma, A., Brainard, D.M., Symonds, W.T., McHutchison, J.G., Weiland, O., Reesink, H.W., Brown, A., Pol, S., Hezode, C., Esteba

Journal:

Journal of Hepatology

Year:

2014

Language:

english

File:

PDF, 64 KB

english, 2014